SCHEMBL3014863

SCHEMBL3014863

Cl[Mg]c1cccs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL1022377 0.97
SCHEMBL3838136 0.75 FBP1 (0.41)
Bromide SCHEMBL3840716 0.73 FBP1 (0.39)
SCHEMBL72771 0.71
SCHEMBL3843770 0.71
Bromide SCHEMBL1124451 0.69
Hydrochloric Acid SCHEMBL9636987 0.69
SCHEMBL30398774 0.65 L3MBTL1 (0.55)
SCHEMBL11635621 0.64
Bromide SCHEMBL8586526 0.64 SLC6A3 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10221198-B2 Preparation and medical use of triazenes ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) 2019-03-05 US disclosed
US-20170158714-A1 Preparation and Medical Use of Triazenes ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) 2017-06-08 US disclosed
WO-2015197096-A1 PREPARATION AND MEDICAL USE OF TRIAZENES ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) 2015-12-30 WO disclosed
EP-2164825-B1 DI(HETERO)ARYLCYCLOHEXANE DERIVATIVES, THEIR PREPARATION, THEIR USE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM SANOFI SA (FR) 2014-04-30 EP disclosed
CN-101679191-B Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them SANOFI AVENTIS SPA 2014-03-12 CN disclosed
WO-2013019849-A2 SUBSTANTIALLY PURE DISUBSTITUTED BERYLLIUM COMPOUNDS AND USES THEREOF GRAPHEA, INC. (US) 2013-02-07 WO disclosed
US-8076324-B2 Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them SANOFI-AVENTIS (FR) 2011-12-13 US disclosed
US-20100204206-A1 Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them SANOFI-AVENTIS (FR) 2010-08-12 US disclosed
EP-2164825-A1 DI(HETERO)ARYLCYCLOHEXANE DERIVATIVES, THEIR PREPARATION, THEIR USE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM Sanofi-Aventis (FR) 2010-03-24 EP disclosed
CN-101679191-A Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them SANOFI AVENTIS 2010-03-24 CN disclosed
EP-1253152-B1 METHOD OF CONVERTING FUNCTIONAL GROUP THROUGH HALOGEN-METAL EXCHANGE REACTION BANYU PHARMA CO LTD (JP) 2009-11-04 EP disclosed
WO-2008148468-A1 DI(HETERO)ARYLCYCLOHEXANE DERIVATIVES, THEIR PREPARATION, THEIR USE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM SANOFI-AVENTIS (FR) 2008-12-11 WO disclosed
US-7439535-B2 Process for exchanging functional groups by halogen-metal exchange reaction BANYU PHARMACEUTICAL CO., LTD. (JP) 2008-10-21 US disclosed
US-6946559-B2 Replacing a halogen atom with an electrophilic group (e.g., a formyl group) using either a mixture of an organomagnesium halide and an alkyllithium or a reaction product of the two, such as trialkylmagnesium lithium BANYU PHARMACEUTICAL CO., LTD. (JP) 2005-09-20 US disclosed
US-20050156336-A1 Process for exchanging functional groups by halogen-metal exchange reaction MSD K.K. (JP) 2005-07-21 US disclosed
US-20030130511-A1 Method of converting functional group through halogen-metal exchange reaction MSD K.K. (JP) 2003-07-10 US disclosed
EP-1253152-A1 METHOD OF CONVERTING FUNCTIONAL GROUP THROUGH HALOGEN-METAL EXCHANGE REACTION BANYU PHARMACEUTICAL CO., LTD. (JP) 2002-10-30 EP disclosed
US-4310674-A Oxazolidine propionic acid methyl esters CARTER-WALLACE, INC. (US) 1982-01-12 US disclosed
US-4275198-A Method for preparing basic dithienyl compounds CARTER-WALLACE INC. (US) 1981-06-23 US disclosed